Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®

The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops using connected device CONNECTDROP® The main questions it aims to answer are: * The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient * The adherence profile of each patient * The association between the adherence profile, the objective adherence data and the clinical data. Participants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.

NCT Number	NCT07206628
Lead Sponsor	Laboratoires Thea
Conditions	Adherence to Glaucoma Therapy
Enrollment	200 participants
Start Date	2025-09-19
Primary Completion	2026-09 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2025-11-17